| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 204 | 2026 | 3763 | 16.870 |
Why?
|
| Neuroimaging | 72 | 2026 | 385 | 15.450 |
Why?
|
| Brain | 105 | 2026 | 3175 | 10.980 |
Why?
|
| Diffusion Tensor Imaging | 37 | 2026 | 255 | 8.690 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 42 | 2026 | 171 | 7.920 |
Why?
|
| Prenatal Diagnosis | 29 | 2026 | 612 | 5.680 |
Why?
|
| Brain Diseases | 19 | 2021 | 299 | 4.990 |
Why?
|
| Tomography, X-Ray Computed | 59 | 2025 | 2065 | 4.960 |
Why?
|
| Hypoxia-Ischemia, Brain | 20 | 2021 | 95 | 4.640 |
Why?
|
| Cerebellar Diseases | 21 | 2021 | 78 | 4.440 |
Why?
|
| Image Enhancement | 20 | 2018 | 159 | 4.350 |
Why?
|
| Cerebellum | 33 | 2023 | 441 | 4.130 |
Why?
|
| Hydrocephalus | 17 | 2025 | 245 | 4.030 |
Why?
|
| Ultrasonography | 24 | 2021 | 943 | 3.950 |
Why?
|
| Nervous System Malformations | 11 | 2024 | 135 | 3.780 |
Why?
|
| Arnold-Chiari Malformation | 9 | 2024 | 51 | 3.520 |
Why?
|
| Child | 187 | 2026 | 26341 | 3.260 |
Why?
|
| Brain Injuries | 14 | 2025 | 710 | 3.230 |
Why?
|
| Spinal Cord | 12 | 2026 | 255 | 3.190 |
Why?
|
| Humans | 382 | 2026 | 131163 | 3.030 |
Why?
|
| Craniocerebral Trauma | 10 | 2022 | 144 | 3.000 |
Why?
|
| Encephalocele | 9 | 2026 | 60 | 2.920 |
Why?
|
| Abnormalities, Multiple | 16 | 2023 | 963 | 2.710 |
Why?
|
| Infant, Newborn | 97 | 2026 | 8635 | 2.700 |
Why?
|
| Neural Tube Defects | 6 | 2026 | 330 | 2.620 |
Why?
|
| Fetal Diseases | 18 | 2018 | 440 | 2.590 |
Why?
|
| Diagnosis, Differential | 52 | 2024 | 1882 | 2.530 |
Why?
|
| Spinal Dysraphism | 6 | 2026 | 261 | 2.480 |
Why?
|
| Child, Preschool | 116 | 2026 | 15110 | 2.470 |
Why?
|
| Infant | 113 | 2026 | 13352 | 2.440 |
Why?
|
| Brain Neoplasms | 16 | 2024 | 1306 | 2.390 |
Why?
|
| Brain Ischemia | 12 | 2023 | 266 | 2.380 |
Why?
|
| Brain Stem | 12 | 2022 | 108 | 2.340 |
Why?
|
| Female | 223 | 2026 | 70963 | 2.210 |
Why?
|
| Contrast Media | 20 | 2021 | 474 | 2.140 |
Why?
|
| Skull | 8 | 2025 | 149 | 2.140 |
Why?
|
| Fetus | 12 | 2023 | 568 | 2.110 |
Why?
|
| Kidney Diseases, Cystic | 8 | 2023 | 44 | 1.990 |
Why?
|
| Spinal Cord Neoplasms | 5 | 2023 | 66 | 1.990 |
Why?
|
| White Matter | 9 | 2025 | 219 | 1.970 |
Why?
|
| Echoencephalography | 7 | 2018 | 28 | 1.880 |
Why?
|
| Male | 183 | 2026 | 64957 | 1.850 |
Why?
|
| Eye Abnormalities | 8 | 2023 | 105 | 1.790 |
Why?
|
| Rhombencephalon | 2 | 2026 | 63 | 1.770 |
Why?
|
| Child Abuse | 5 | 2022 | 228 | 1.620 |
Why?
|
| Retrospective Studies | 78 | 2026 | 17753 | 1.590 |
Why?
|
| Pregnancy | 49 | 2026 | 7512 | 1.590 |
Why?
|
| Adolescent | 86 | 2025 | 20987 | 1.500 |
Why?
|
| Radiology | 7 | 2025 | 122 | 1.490 |
Why?
|
| Connectome | 5 | 2020 | 111 | 1.480 |
Why?
|
| Image Interpretation, Computer-Assisted | 13 | 2019 | 229 | 1.480 |
Why?
|
| Vein of Galen Malformations | 4 | 2026 | 21 | 1.460 |
Why?
|
| Spinal Injuries | 3 | 2022 | 35 | 1.460 |
Why?
|
| Ultrasonography, Prenatal | 16 | 2026 | 986 | 1.450 |
Why?
|
| Dermoid Cyst | 5 | 2021 | 33 | 1.430 |
Why?
|
| Diagnostic Imaging | 6 | 2026 | 305 | 1.410 |
Why?
|
| Agenesis of Corpus Callosum | 5 | 2022 | 49 | 1.370 |
Why?
|
| Image Processing, Computer-Assisted | 18 | 2018 | 587 | 1.330 |
Why?
|
| Magnetic Resonance Angiography | 8 | 2017 | 161 | 1.330 |
Why?
|
| Diffuse Axonal Injury | 5 | 2022 | 10 | 1.320 |
Why?
|
| Sensitivity and Specificity | 29 | 2025 | 2085 | 1.310 |
Why?
|
| Pediatrics | 6 | 2025 | 1252 | 1.310 |
Why?
|
| Skull Fractures | 6 | 2017 | 46 | 1.270 |
Why?
|
| Stroke | 12 | 2022 | 1061 | 1.210 |
Why?
|
| Neurocutaneous Syndromes | 4 | 2018 | 17 | 1.210 |
Why?
|
| Head | 8 | 2023 | 111 | 1.200 |
Why?
|
| Cerebral Hemorrhage | 4 | 2017 | 158 | 1.190 |
Why?
|
| Artificial Intelligence | 5 | 2026 | 369 | 1.190 |
Why?
|
| Aicardi Syndrome | 2 | 2022 | 17 | 1.090 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2026 | 85 | 1.090 |
Why?
|
| Infant, Newborn, Diseases | 6 | 2018 | 177 | 1.070 |
Why?
|
| Pseudotumor Cerebri | 3 | 2025 | 62 | 1.070 |
Why?
|
| Tuberous Sclerosis | 3 | 2019 | 147 | 1.070 |
Why?
|
| Corpus Callosum | 7 | 2022 | 104 | 1.060 |
Why?
|
| Hematoma, Subdural | 4 | 2019 | 32 | 1.050 |
Why?
|
| Cerebral Ventricles | 7 | 2017 | 80 | 1.040 |
Why?
|
| Radiology Department, Hospital | 3 | 2026 | 26 | 1.030 |
Why?
|
| Intracranial Hemorrhages | 9 | 2015 | 79 | 1.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2015 | 260 | 1.010 |
Why?
|
| Neonatal Screening | 4 | 2014 | 207 | 0.990 |
Why?
|
| Cerebrovascular Circulation | 8 | 2024 | 487 | 0.950 |
Why?
|
| Sinus Thrombosis, Intracranial | 6 | 2017 | 50 | 0.950 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2025 | 37 | 0.940 |
Why?
|
| Hypothermia, Induced | 7 | 2019 | 172 | 0.930 |
Why?
|
| Iron Metabolism Disorders | 1 | 2025 | 14 | 0.920 |
Why?
|
| Electric Power Supplies | 2 | 2024 | 21 | 0.920 |
Why?
|
| Neuroradiography | 3 | 2026 | 7 | 0.920 |
Why?
|
| Meningomyelocele | 6 | 2026 | 260 | 0.910 |
Why?
|
| Neck | 5 | 2018 | 140 | 0.910 |
Why?
|
| Near Drowning | 1 | 2025 | 29 | 0.910 |
Why?
|
| Calcinosis | 5 | 2014 | 180 | 0.910 |
Why?
|
| Scoliosis | 3 | 2017 | 147 | 0.900 |
Why?
|
| Medulloblastoma | 6 | 2020 | 377 | 0.890 |
Why?
|
| Infratentorial Neoplasms | 5 | 2020 | 32 | 0.890 |
Why?
|
| Glioblastoma | 2 | 2022 | 371 | 0.870 |
Why?
|
| Encephalitis | 3 | 2022 | 122 | 0.870 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 63 | 0.860 |
Why?
|
| Sturge-Weber Syndrome | 3 | 2009 | 9 | 0.850 |
Why?
|
| Foreign Bodies | 2 | 2024 | 98 | 0.850 |
Why?
|
| Brain Edema | 4 | 2021 | 66 | 0.850 |
Why?
|
| Fetoscopy | 5 | 2026 | 460 | 0.830 |
Why?
|
| Pons | 5 | 2024 | 34 | 0.830 |
Why?
|
| Neck Injuries | 2 | 2014 | 22 | 0.820 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 9 | 0.810 |
Why?
|
| Cerebral Veins | 4 | 2021 | 23 | 0.810 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.810 |
Why?
|
| Glioma | 5 | 2022 | 494 | 0.800 |
Why?
|
| Birth Injuries | 3 | 2014 | 20 | 0.800 |
Why?
|
| Airway Obstruction | 4 | 2016 | 173 | 0.800 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 31 | 0.790 |
Why?
|
| Neurodegenerative Diseases | 2 | 2025 | 280 | 0.780 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2025 | 325 | 0.760 |
Why?
|
| Meningitis, Bacterial | 4 | 2022 | 98 | 0.750 |
Why?
|
| Vena Cava, Inferior | 2 | 2020 | 93 | 0.750 |
Why?
|
| Iron | 1 | 2025 | 304 | 0.740 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2022 | 20 | 0.730 |
Why?
|
| Neurofibromatosis 1 | 4 | 2026 | 73 | 0.730 |
Why?
|
| Radiation Exposure | 1 | 2023 | 45 | 0.730 |
Why?
|
| Cranial Fossa, Posterior | 5 | 2017 | 24 | 0.720 |
Why?
|
| Reproducibility of Results | 17 | 2026 | 2904 | 0.710 |
Why?
|
| Anisotropy | 16 | 2019 | 117 | 0.710 |
Why?
|
| Peritoneal Neoplasms | 2 | 2015 | 47 | 0.710 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 61 | 0.700 |
Why?
|
| Ciliopathies | 1 | 2021 | 11 | 0.700 |
Why?
|
| Imaging, Three-Dimensional | 7 | 2015 | 371 | 0.690 |
Why?
|
| Artifacts | 5 | 2013 | 100 | 0.690 |
Why?
|
| Adult | 43 | 2025 | 31282 | 0.680 |
Why?
|
| Head and Neck Neoplasms | 3 | 2025 | 638 | 0.680 |
Why?
|
| Postnatal Care | 2 | 2011 | 54 | 0.680 |
Why?
|
| Scalp | 1 | 2021 | 59 | 0.680 |
Why?
|
| Astrocytoma | 5 | 2020 | 101 | 0.670 |
Why?
|
| Head Injuries, Closed | 3 | 2014 | 46 | 0.660 |
Why?
|
| Neuromyelitis Optica | 3 | 2019 | 34 | 0.660 |
Why?
|
| Congenital Abnormalities | 5 | 2016 | 330 | 0.660 |
Why?
|
| Asphyxia Neonatorum | 4 | 2019 | 23 | 0.650 |
Why?
|
| Cerebrovascular Disorders | 4 | 2024 | 111 | 0.650 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2017 | 112 | 0.650 |
Why?
|
| Gray Matter | 2 | 2025 | 50 | 0.650 |
Why?
|
| Precision Medicine | 1 | 2024 | 388 | 0.640 |
Why?
|
| Edema | 3 | 2019 | 130 | 0.630 |
Why?
|
| Central Nervous System Diseases | 3 | 2015 | 98 | 0.630 |
Why?
|
| Radiology Information Systems | 3 | 2020 | 28 | 0.630 |
Why?
|
| Fetal Development | 1 | 2021 | 121 | 0.620 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 158 | 0.610 |
Why?
|
| Back Pain | 3 | 2017 | 30 | 0.610 |
Why?
|
| Brain Death | 2 | 2018 | 73 | 0.600 |
Why?
|
| Brain Damage, Chronic | 3 | 2014 | 27 | 0.600 |
Why?
|
| Gadolinium | 4 | 2017 | 110 | 0.600 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 554 | 0.600 |
Why?
|
| Syringomyelia | 2 | 2016 | 17 | 0.580 |
Why?
|
| Cerebellar Neoplasms | 4 | 2017 | 317 | 0.580 |
Why?
|
| Spine | 4 | 2013 | 153 | 0.570 |
Why?
|
| Basal Ganglia | 1 | 2019 | 60 | 0.570 |
Why?
|
| Abdomen | 4 | 2018 | 126 | 0.570 |
Why?
|
| Developmental Disabilities | 5 | 2018 | 781 | 0.570 |
Why?
|
| Leukoaraiosis | 1 | 2018 | 4 | 0.570 |
Why?
|
| Malformations of Cortical Development | 3 | 2017 | 60 | 0.560 |
Why?
|
| Self-Injurious Behavior | 1 | 2019 | 67 | 0.550 |
Why?
|
| Autopsy | 2 | 2011 | 111 | 0.550 |
Why?
|
| Retina | 8 | 2023 | 425 | 0.550 |
Why?
|
| Lipomatosis | 2 | 2015 | 15 | 0.550 |
Why?
|
| Leukomalacia, Periventricular | 2 | 2015 | 16 | 0.540 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2013 | 327 | 0.540 |
Why?
|
| Anterior Cerebral Artery | 2 | 2016 | 6 | 0.540 |
Why?
|
| Retinal Hemorrhage | 2 | 2015 | 16 | 0.540 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2017 | 5 | 0.530 |
Why?
|
| Venous Thrombosis | 2 | 2015 | 164 | 0.520 |
Why?
|
| Skull Base Neoplasms | 2 | 2022 | 39 | 0.520 |
Why?
|
| Infant, Premature | 5 | 2014 | 872 | 0.520 |
Why?
|
| Spasms, Infantile | 4 | 2017 | 166 | 0.510 |
Why?
|
| Hemangioma, Cavernous | 1 | 2017 | 19 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 275 | 0.510 |
Why?
|
| Diverticulum | 1 | 2017 | 22 | 0.510 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2017 | 19 | 0.510 |
Why?
|
| Intracranial Hypertension | 3 | 2025 | 134 | 0.510 |
Why?
|
| Vascular Resistance | 2 | 2016 | 182 | 0.500 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 32 | 0.490 |
Why?
|
| Visual Pathways | 2 | 2021 | 84 | 0.490 |
Why?
|
| Neurology | 2 | 2015 | 116 | 0.490 |
Why?
|
| Teratoma | 2 | 2010 | 120 | 0.490 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2018 | 326 | 0.490 |
Why?
|
| Bone Diseases, Developmental | 1 | 2016 | 64 | 0.480 |
Why?
|
| Young Adult | 22 | 2025 | 10103 | 0.480 |
Why?
|
| Spinal Cord Injuries | 2 | 2014 | 273 | 0.480 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2016 | 67 | 0.480 |
Why?
|
| Biomedical Research | 1 | 2022 | 561 | 0.480 |
Why?
|
| Geniculate Bodies | 1 | 2016 | 10 | 0.480 |
Why?
|
| Moyamoya Disease | 2 | 2013 | 41 | 0.470 |
Why?
|
| Ataxia | 6 | 2022 | 160 | 0.470 |
Why?
|
| Total Quality Management | 1 | 2016 | 22 | 0.470 |
Why?
|
| Neoplasm Seeding | 1 | 2015 | 10 | 0.460 |
Why?
|
| Prognosis | 15 | 2024 | 4886 | 0.460 |
Why?
|
| Spinal Nerve Roots | 1 | 2015 | 19 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 339 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 351 | 0.450 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2015 | 50 | 0.450 |
Why?
|
| Cysts | 5 | 2017 | 80 | 0.450 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2013 | 79 | 0.440 |
Why?
|
| Hamartoma Syndrome, Multiple | 3 | 2026 | 23 | 0.440 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2013 | 36 | 0.440 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2014 | 83 | 0.440 |
Why?
|
| Liver Neoplasms | 4 | 2012 | 1373 | 0.420 |
Why?
|
| Hydrops Fetalis | 1 | 2015 | 82 | 0.420 |
Why?
|
| Placenta Previa | 1 | 2015 | 66 | 0.420 |
Why?
|
| Optic Atrophy | 2 | 2023 | 42 | 0.420 |
Why?
|
| Skull Base | 5 | 2024 | 49 | 0.420 |
Why?
|
| Microcephaly | 4 | 2021 | 347 | 0.420 |
Why?
|
| Spinal Fractures | 1 | 2014 | 48 | 0.420 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 157 | 0.420 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 130 | 0.420 |
Why?
|
| Malignant Hyperthermia | 1 | 2014 | 18 | 0.420 |
Why?
|
| Visual Cortex | 1 | 2016 | 125 | 0.420 |
Why?
|
| Cranial Fontanelles | 1 | 2014 | 4 | 0.420 |
Why?
|
| Cardiomegaly | 1 | 2015 | 117 | 0.410 |
Why?
|
| Brain Abscess | 2 | 2012 | 54 | 0.410 |
Why?
|
| Cerebrospinal Fluid Pressure | 2 | 2025 | 17 | 0.410 |
Why?
|
| Skin Abnormalities | 1 | 2014 | 34 | 0.410 |
Why?
|
| Disability Evaluation | 2 | 2013 | 191 | 0.410 |
Why?
|
| Pandemics | 2 | 2020 | 1118 | 0.410 |
Why?
|
| Fatal Outcome | 6 | 2017 | 352 | 0.410 |
Why?
|
| Vomiting | 1 | 2014 | 103 | 0.410 |
Why?
|
| Anesthesia, General | 1 | 2015 | 140 | 0.410 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2013 | 7 | 0.410 |
Why?
|
| Eye Diseases | 1 | 2015 | 107 | 0.400 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2014 | 91 | 0.400 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 143 | 0.400 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 32 | 0.400 |
Why?
|
| Anesthetics, Intravenous | 1 | 2013 | 50 | 0.400 |
Why?
|
| Arachnoid Cysts | 2 | 2007 | 9 | 0.400 |
Why?
|
| Brain Mapping | 5 | 2014 | 384 | 0.400 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 279 | 0.400 |
Why?
|
| Migraine with Aura | 1 | 2013 | 16 | 0.400 |
Why?
|
| Propofol | 1 | 2013 | 50 | 0.400 |
Why?
|
| Neoplasm Grading | 2 | 2014 | 274 | 0.400 |
Why?
|
| Cartilage Diseases | 1 | 2013 | 18 | 0.390 |
Why?
|
| Cavernous Sinus | 3 | 2017 | 23 | 0.390 |
Why?
|
| Hematoma, Epidural, Cranial | 2 | 2014 | 10 | 0.390 |
Why?
|
| Hippocampus | 1 | 2018 | 806 | 0.390 |
Why?
|
| Holoprosencephaly | 2 | 2012 | 23 | 0.380 |
Why?
|
| Accidental Falls | 1 | 2014 | 112 | 0.380 |
Why?
|
| Ear | 1 | 2013 | 26 | 0.380 |
Why?
|
| Hearing Loss, Conductive | 1 | 2013 | 16 | 0.380 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2020 | 57 | 0.380 |
Why?
|
| Temporal Bone | 1 | 2013 | 38 | 0.380 |
Why?
|
| Neuroaxonal Dystrophies | 2 | 2025 | 15 | 0.370 |
Why?
|
| Nerve Fibers | 1 | 2013 | 65 | 0.370 |
Why?
|
| Emergencies | 2 | 2006 | 171 | 0.370 |
Why?
|
| Hand Deformities, Congenital | 1 | 2013 | 96 | 0.370 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 468 | 0.370 |
Why?
|
| Synapses | 1 | 2016 | 425 | 0.360 |
Why?
|
| Severity of Illness Index | 9 | 2026 | 3061 | 0.360 |
Why?
|
| Central Nervous System Parasitic Infections | 1 | 2012 | 2 | 0.360 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2012 | 26 | 0.360 |
Why?
|
| Empyema, Subdural | 1 | 2012 | 8 | 0.360 |
Why?
|
| Follow-Up Studies | 19 | 2020 | 5196 | 0.360 |
Why?
|
| Radiographic Image Enhancement | 2 | 2003 | 38 | 0.360 |
Why?
|
| Central Nervous System Bacterial Infections | 1 | 2012 | 6 | 0.360 |
Why?
|
| Zika Virus Infection | 3 | 2021 | 173 | 0.360 |
Why?
|
| Hemangioma | 2 | 2012 | 86 | 0.360 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2012 | 13 | 0.360 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2016 | 682 | 0.360 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 496 | 0.360 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 398 | 0.350 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2012 | 15 | 0.350 |
Why?
|
| Demyelinating Diseases | 3 | 2009 | 68 | 0.350 |
Why?
|
| Tectorial Membrane | 1 | 2011 | 5 | 0.350 |
Why?
|
| Infant Nutrition Disorders | 1 | 2011 | 15 | 0.350 |
Why?
|
| Anencephaly | 1 | 2011 | 11 | 0.340 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2014 | 260 | 0.340 |
Why?
|
| Referral and Consultation | 1 | 2015 | 564 | 0.330 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2026 | 629 | 0.330 |
Why?
|
| Gestational Age | 10 | 2026 | 1224 | 0.330 |
Why?
|
| Sinusitis | 3 | 2020 | 118 | 0.320 |
Why?
|
| Cohort Studies | 7 | 2023 | 5063 | 0.320 |
Why?
|
| Diagnostic Errors | 2 | 2015 | 345 | 0.320 |
Why?
|
| Homeostasis | 4 | 2016 | 712 | 0.320 |
Why?
|
| Posture | 2 | 2016 | 138 | 0.310 |
Why?
|
| Hysterotomy | 3 | 2026 | 129 | 0.310 |
Why?
|
| Status Epilepticus | 1 | 2012 | 159 | 0.310 |
Why?
|
| Mental Disorders | 1 | 2018 | 910 | 0.300 |
Why?
|
| Meningeal Neoplasms | 3 | 2017 | 220 | 0.300 |
Why?
|
| Splenic Neoplasms | 1 | 2009 | 12 | 0.300 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 2 | 2019 | 10 | 0.300 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 395 | 0.300 |
Why?
|
| Twins, Conjoined | 1 | 2009 | 29 | 0.300 |
Why?
|
| Nerve Degeneration | 3 | 2016 | 128 | 0.290 |
Why?
|
| Spinal Cord Diseases | 2 | 2022 | 32 | 0.290 |
Why?
|
| Periodicals as Topic | 3 | 2025 | 182 | 0.290 |
Why?
|
| Herniorrhaphy | 1 | 2009 | 71 | 0.290 |
Why?
|
| Mediastinal Neoplasms | 2 | 2014 | 36 | 0.290 |
Why?
|
| Mesencephalon | 1 | 2009 | 38 | 0.290 |
Why?
|
| Seizures | 3 | 2025 | 890 | 0.290 |
Why?
|
| Acrocallosal Syndrome | 1 | 2008 | 1 | 0.280 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 15 | 0.280 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 853 | 0.280 |
Why?
|
| Hepatoblastoma | 1 | 2011 | 204 | 0.280 |
Why?
|
| Ependymoma | 3 | 2019 | 137 | 0.280 |
Why?
|
| Cranial Sutures | 1 | 2008 | 32 | 0.280 |
Why?
|
| Supratentorial Neoplasms | 2 | 2020 | 38 | 0.280 |
Why?
|
| Ameloblastoma | 1 | 2008 | 3 | 0.270 |
Why?
|
| Cerebrospinal Fluid Leak | 2 | 2025 | 47 | 0.270 |
Why?
|
| Mandibular Neoplasms | 1 | 2008 | 9 | 0.270 |
Why?
|
| Paranasal Sinuses | 2 | 2020 | 17 | 0.270 |
Why?
|
| Syndrome | 6 | 2020 | 1155 | 0.270 |
Why?
|
| Nasopharyngeal Diseases | 1 | 2007 | 4 | 0.270 |
Why?
|
| Pelvis | 2 | 2018 | 70 | 0.270 |
Why?
|
| Zika Virus | 2 | 2021 | 150 | 0.260 |
Why?
|
| Neuroblastoma | 2 | 2017 | 546 | 0.260 |
Why?
|
| Choristoma | 1 | 2007 | 43 | 0.260 |
Why?
|
| Ecchymosis | 1 | 2007 | 11 | 0.260 |
Why?
|
| Nose Neoplasms | 2 | 2007 | 31 | 0.260 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2007 | 12 | 0.250 |
Why?
|
| Central Nervous System | 2 | 2023 | 269 | 0.250 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 233 | 0.250 |
Why?
|
| Orbital Neoplasms | 1 | 2007 | 50 | 0.250 |
Why?
|
| Cloaca | 1 | 2006 | 13 | 0.250 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2007 | 64 | 0.240 |
Why?
|
| Orbital Diseases | 1 | 2007 | 64 | 0.240 |
Why?
|
| Ileal Diseases | 1 | 2006 | 26 | 0.240 |
Why?
|
| Frontal Bone | 2 | 2007 | 15 | 0.240 |
Why?
|
| Carcinoma | 1 | 2009 | 291 | 0.240 |
Why?
|
| Atrophy | 5 | 2018 | 247 | 0.240 |
Why?
|
| Publishing | 2 | 2025 | 105 | 0.240 |
Why?
|
| alpha-Fetoproteins | 2 | 2021 | 125 | 0.240 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2008 | 182 | 0.240 |
Why?
|
| Neurofibromatosis 2 | 1 | 2026 | 12 | 0.240 |
Why?
|
| Intellectual Disability | 3 | 2023 | 1089 | 0.240 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2026 | 24 | 0.230 |
Why?
|
| Intussusception | 1 | 2006 | 54 | 0.230 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2026 | 22 | 0.230 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2026 | 22 | 0.230 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2005 | 15 | 0.230 |
Why?
|
| Oxygen | 2 | 2019 | 548 | 0.230 |
Why?
|
| Early Diagnosis | 4 | 2018 | 195 | 0.230 |
Why?
|
| Cerebral Infarction | 2 | 2004 | 46 | 0.230 |
Why?
|
| Radiography | 4 | 2013 | 743 | 0.230 |
Why?
|
| Neural Pathways | 2 | 2017 | 270 | 0.230 |
Why?
|
| Liver Diseases | 1 | 2009 | 385 | 0.220 |
Why?
|
| Neuroglia | 1 | 2007 | 224 | 0.220 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2005 | 42 | 0.220 |
Why?
|
| Mutation | 5 | 2024 | 6099 | 0.220 |
Why?
|
| Cerebral Angiography | 5 | 2022 | 106 | 0.220 |
Why?
|
| Treatment Outcome | 11 | 2026 | 12936 | 0.220 |
Why?
|
| Pituitary Gland | 1 | 2005 | 74 | 0.220 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2017 | 161 | 0.220 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 211 | 0.220 |
Why?
|
| Cranial Nerves | 1 | 2024 | 21 | 0.220 |
Why?
|
| Phenotype | 3 | 2018 | 4497 | 0.220 |
Why?
|
| Globus Pallidus | 2 | 2018 | 64 | 0.210 |
Why?
|
| Choriocarcinoma | 1 | 2004 | 3 | 0.210 |
Why?
|
| Ocular Motility Disorders | 3 | 2014 | 38 | 0.210 |
Why?
|
| Nerve Net | 2 | 2020 | 254 | 0.210 |
Why?
|
| Brain Stem Neoplasms | 2 | 2016 | 42 | 0.210 |
Why?
|
| Editorial Policies | 1 | 2025 | 49 | 0.210 |
Why?
|
| Achondroplasia | 2 | 2014 | 24 | 0.210 |
Why?
|
| Urogenital Abnormalities | 1 | 2006 | 155 | 0.210 |
Why?
|
| Crohn Disease | 2 | 2015 | 292 | 0.210 |
Why?
|
| Laser Coagulation | 1 | 2005 | 114 | 0.210 |
Why?
|
| Algorithms | 4 | 2015 | 1680 | 0.210 |
Why?
|
| Meninges | 1 | 2023 | 22 | 0.200 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2025 | 361 | 0.200 |
Why?
|
| Linear Models | 6 | 2016 | 688 | 0.200 |
Why?
|
| Aging | 1 | 2011 | 1242 | 0.200 |
Why?
|
| Olivary Nucleus | 2 | 2014 | 14 | 0.200 |
Why?
|
| Ribonuclease III | 1 | 2024 | 100 | 0.200 |
Why?
|
| Meningocele | 1 | 2003 | 18 | 0.200 |
Why?
|
| Embolization, Therapeutic | 1 | 2026 | 233 | 0.200 |
Why?
|
| Cervical Vertebrae | 2 | 2016 | 102 | 0.190 |
Why?
|
| Reference Values | 3 | 2012 | 676 | 0.190 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 2017 | 28 | 0.190 |
Why?
|
| Intracranial Pressure | 2 | 2021 | 214 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2024 | 160 | 0.190 |
Why?
|
| Constriction, Pathologic | 3 | 2014 | 221 | 0.180 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2022 | 32 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2026 | 3436 | 0.180 |
Why?
|
| Patient Safety | 2 | 2025 | 443 | 0.180 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 9 | 0.180 |
Why?
|
| Fetofetal Transfusion | 1 | 2005 | 206 | 0.180 |
Why?
|
| Temporal Lobe | 1 | 2022 | 110 | 0.180 |
Why?
|
| Heart Defects, Congenital | 1 | 2014 | 1889 | 0.180 |
Why?
|
| Burkitt Lymphoma | 1 | 2003 | 131 | 0.180 |
Why?
|
| Tinnitus | 1 | 2022 | 23 | 0.180 |
Why?
|
| Abdominal Injuries | 1 | 2003 | 123 | 0.180 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2013 | 102 | 0.170 |
Why?
|
| Career Mobility | 1 | 2022 | 52 | 0.170 |
Why?
|
| Spinal Cord Ischemia | 1 | 2001 | 31 | 0.170 |
Why?
|
| Urinary Bladder | 1 | 2003 | 220 | 0.170 |
Why?
|
| Sarcoma | 1 | 2024 | 219 | 0.170 |
Why?
|
| Hyperemia | 1 | 2021 | 30 | 0.170 |
Why?
|
| Pyramidal Tracts | 2 | 2014 | 33 | 0.170 |
Why?
|
| Parotitis | 1 | 2001 | 6 | 0.170 |
Why?
|
| Job Satisfaction | 1 | 2022 | 100 | 0.170 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 218 | 0.170 |
Why?
|
| Pelvic Bones | 2 | 2014 | 25 | 0.160 |
Why?
|
| Predictive Value of Tests | 6 | 2025 | 2304 | 0.160 |
Why?
|
| Radiation Dosage | 2 | 2019 | 132 | 0.160 |
Why?
|
| Anodontia | 1 | 2001 | 33 | 0.160 |
Why?
|
| Granuloma, Giant Cell | 1 | 2020 | 12 | 0.160 |
Why?
|
| Denosumab | 1 | 2020 | 13 | 0.160 |
Why?
|
| Placenta | 1 | 2005 | 504 | 0.160 |
Why?
|
| Subtraction Technique | 2 | 2011 | 36 | 0.160 |
Why?
|
| Fever of Unknown Origin | 1 | 2001 | 44 | 0.160 |
Why?
|
| Organizational Objectives | 1 | 2020 | 34 | 0.160 |
Why?
|
| Computer-Aided Design | 1 | 2020 | 18 | 0.160 |
Why?
|
| Teleradiology | 1 | 2020 | 6 | 0.160 |
Why?
|
| Ganglioglioma | 1 | 2020 | 20 | 0.160 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 36 | 0.160 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 9 | 0.160 |
Why?
|
| Ectodermal Dysplasia | 1 | 2001 | 62 | 0.160 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2000 | 26 | 0.160 |
Why?
|
| Bone Density Conservation Agents | 1 | 2020 | 56 | 0.160 |
Why?
|
| Ear, Inner | 1 | 2020 | 41 | 0.160 |
Why?
|
| Hemangiopericytoma | 1 | 2000 | 11 | 0.160 |
Why?
|
| Rhabdoid Tumor | 1 | 2000 | 46 | 0.150 |
Why?
|
| Nystagmus, Pathologic | 2 | 2017 | 23 | 0.150 |
Why?
|
| Hospitals, Community | 1 | 2020 | 51 | 0.150 |
Why?
|
| Efficiency, Organizational | 2 | 2020 | 56 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2018 | 259 | 0.150 |
Why?
|
| Age Factors | 4 | 2018 | 2825 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 1075 | 0.150 |
Why?
|
| Models, Anatomic | 1 | 2020 | 105 | 0.150 |
Why?
|
| Workplace | 1 | 2020 | 80 | 0.150 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 88 | 0.150 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 1999 | 3 | 0.150 |
Why?
|
| Optic Nerve Glioma | 2 | 2017 | 22 | 0.150 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2016 | 20 | 0.150 |
Why?
|
| Postoperative Complications | 3 | 2020 | 3147 | 0.150 |
Why?
|
| Child Health Services | 1 | 2020 | 88 | 0.150 |
Why?
|
| Photons | 1 | 2019 | 60 | 0.150 |
Why?
|
| Dilatation, Pathologic | 2 | 2010 | 73 | 0.150 |
Why?
|
| Radiation Protection | 1 | 2019 | 51 | 0.140 |
Why?
|
| Substantia Nigra | 1 | 2018 | 35 | 0.140 |
Why?
|
| Central Nervous System Infections | 1 | 1999 | 27 | 0.140 |
Why?
|
| Workflow | 2 | 2020 | 144 | 0.140 |
Why?
|
| Colitis, Ischemic | 1 | 2018 | 3 | 0.140 |
Why?
|
| Evaluation Studies as Topic | 1 | 2018 | 225 | 0.140 |
Why?
|
| Movement Disorders | 1 | 2021 | 218 | 0.140 |
Why?
|
| Optic Nerve | 2 | 2017 | 110 | 0.140 |
Why?
|
| Lyme Disease | 1 | 1999 | 34 | 0.140 |
Why?
|
| Radiation Injuries | 1 | 2019 | 141 | 0.140 |
Why?
|
| Intestine, Small | 1 | 2000 | 291 | 0.140 |
Why?
|
| Histones | 1 | 2022 | 541 | 0.130 |
Why?
|
| Hernia | 2 | 2009 | 14 | 0.130 |
Why?
|
| Thorax | 1 | 2018 | 63 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2019 | 6459 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2026 | 802 | 0.130 |
Why?
|
| Glasgow Coma Scale | 3 | 2017 | 200 | 0.130 |
Why?
|
| Megalencephaly | 1 | 2018 | 59 | 0.130 |
Why?
|
| Chondroma | 1 | 2017 | 5 | 0.130 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 638 | 0.130 |
Why?
|
| Microbubbles | 1 | 2017 | 8 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2465 | 0.130 |
Why?
|
| Kidney | 1 | 2004 | 1282 | 0.130 |
Why?
|
| Epilepsy | 2 | 2016 | 876 | 0.130 |
Why?
|
| Organizations, Nonprofit | 1 | 2017 | 27 | 0.130 |
Why?
|
| Aged | 9 | 2025 | 21025 | 0.130 |
Why?
|
| Cognition Disorders | 3 | 2018 | 556 | 0.130 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 179 | 0.130 |
Why?
|
| Biomarkers | 4 | 2015 | 3385 | 0.130 |
Why?
|
| Hemodynamics | 3 | 2016 | 810 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2018 | 115 | 0.120 |
Why?
|
| Ischemia | 1 | 2000 | 359 | 0.120 |
Why?
|
| Discitis | 2 | 2015 | 7 | 0.120 |
Why?
|
| Uncertainty | 1 | 2017 | 99 | 0.120 |
Why?
|
| Middle Aged | 7 | 2025 | 28601 | 0.120 |
Why?
|
| Orbit | 1 | 2017 | 75 | 0.120 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1996 | 13 | 0.120 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2016 | 27 | 0.120 |
Why?
|
| Mitochondria | 1 | 2022 | 785 | 0.120 |
Why?
|
| Thermometry | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 126 | 0.120 |
Why?
|
| Hemispherectomy | 1 | 2016 | 28 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 56 | 0.110 |
Why?
|
| Observer Variation | 2 | 2015 | 311 | 0.110 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2015 | 9 | 0.110 |
Why?
|
| Immunocompromised Host | 2 | 2015 | 315 | 0.110 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2015 | 11 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 205 | 0.110 |
Why?
|
| Skin | 1 | 2018 | 545 | 0.110 |
Why?
|
| Multidetector Computed Tomography | 1 | 2015 | 33 | 0.110 |
Why?
|
| Body Temperature | 1 | 2015 | 126 | 0.110 |
Why?
|
| Cervical Cord | 1 | 2015 | 9 | 0.110 |
Why?
|
| Biopsy, Needle | 2 | 2007 | 204 | 0.110 |
Why?
|
| Oligodendroglioma | 1 | 2015 | 25 | 0.110 |
Why?
|
| Battered Child Syndrome | 1 | 2015 | 3 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2000 | 372 | 0.110 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 808 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2015 | 58 | 0.110 |
Why?
|
| Muscular Dystrophies | 1 | 2015 | 51 | 0.110 |
Why?
|
| Point Mutation | 1 | 1996 | 333 | 0.110 |
Why?
|
| Functional Neuroimaging | 1 | 2014 | 30 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 895 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2018 | 159 | 0.110 |
Why?
|
| Foramen Magnum | 1 | 2014 | 7 | 0.110 |
Why?
|
| Statistics, Nonparametric | 3 | 2021 | 423 | 0.110 |
Why?
|
| Otitis Media | 1 | 2015 | 88 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 236 | 0.110 |
Why?
|
| Cockayne Syndrome | 1 | 2014 | 6 | 0.110 |
Why?
|
| Spinocerebellar Tracts | 1 | 2014 | 4 | 0.110 |
Why?
|
| Central Nervous System Cysts | 1 | 2014 | 12 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 376 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2015 | 103 | 0.100 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2016 | 170 | 0.100 |
Why?
|
| Epispadias | 1 | 2014 | 2 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2019 | 1445 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2015 | 184 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 26 | 0.100 |
Why?
|
| Mosaicism | 1 | 1996 | 248 | 0.100 |
Why?
|
| Trauma, Nervous System | 1 | 2014 | 4 | 0.100 |
Why?
|
| Seminoma | 1 | 2014 | 5 | 0.100 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2014 | 7 | 0.100 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2013 | 19 | 0.100 |
Why?
|
| Term Birth | 1 | 2014 | 31 | 0.100 |
Why?
|
| Pelvic Floor | 1 | 2014 | 36 | 0.100 |
Why?
|
| Bladder Exstrophy | 1 | 2014 | 13 | 0.100 |
Why?
|
| Apraxias | 1 | 2014 | 14 | 0.100 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2013 | 2 | 0.100 |
Why?
|
| Forecasting | 1 | 2015 | 351 | 0.100 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2013 | 25 | 0.100 |
Why?
|
| Meningioma | 2 | 2017 | 151 | 0.100 |
Why?
|
| Multiple Trauma | 1 | 2014 | 61 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2015 | 824 | 0.100 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2013 | 6 | 0.100 |
Why?
|
| Septum Pellucidum | 1 | 2013 | 4 | 0.100 |
Why?
|
| Sclerotherapy | 1 | 2013 | 36 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2016 | 210 | 0.100 |
Why?
|
| Hemiplegia | 1 | 2013 | 40 | 0.100 |
Why?
|
| Resuscitation | 1 | 2016 | 258 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2016 | 514 | 0.100 |
Why?
|
| Arteriovenous Malformations | 1 | 2013 | 49 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 321 | 0.100 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 71 | 0.100 |
Why?
|
| Frontal Lobe | 2 | 2014 | 110 | 0.100 |
Why?
|
| Subthalamic Nucleus | 1 | 2013 | 52 | 0.100 |
Why?
|
| Myotonic Dystrophy | 1 | 2014 | 73 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 81 | 0.100 |
Why?
|
| Disease Progression | 3 | 2012 | 2200 | 0.090 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2012 | 44 | 0.090 |
Why?
|
| Cranial Sinuses | 1 | 2012 | 16 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 2015 | 254 | 0.090 |
Why?
|
| Congenital Microtia | 1 | 2013 | 26 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2015 | 358 | 0.090 |
Why?
|
| Case-Control Studies | 6 | 2014 | 3359 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2013 | 172 | 0.090 |
Why?
|
| Tegmentum Mesencephali | 1 | 2012 | 2 | 0.090 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2012 | 6 | 0.090 |
Why?
|
| Pregnancy, Twin | 1 | 2013 | 191 | 0.090 |
Why?
|
| Vigabatrin | 1 | 2012 | 19 | 0.090 |
Why?
|
| Brain Chemistry | 3 | 2008 | 110 | 0.090 |
Why?
|
| Aorta, Abdominal | 1 | 2012 | 96 | 0.090 |
Why?
|
| Prevalence | 4 | 2025 | 2701 | 0.090 |
Why?
|
| Radiologists | 2 | 2022 | 53 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2012 | 76 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 417 | 0.090 |
Why?
|
| Acute Disease | 3 | 2005 | 1153 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2012 | 99 | 0.090 |
Why?
|
| Organ Size | 2 | 2021 | 407 | 0.090 |
Why?
|
| Prednisolone | 1 | 2012 | 74 | 0.090 |
Why?
|
| Visual Perception | 1 | 2012 | 128 | 0.090 |
Why?
|
| Cerebral Palsy | 1 | 2013 | 86 | 0.090 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 82 | 0.090 |
Why?
|
| Medulla Oblongata | 1 | 2011 | 24 | 0.090 |
Why?
|
| Propranolol | 1 | 2012 | 110 | 0.090 |
Why?
|
| Neurologic Examination | 2 | 2014 | 185 | 0.090 |
Why?
|
| Knee Joint | 1 | 2012 | 177 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 393 | 0.080 |
Why?
|
| Cognition | 1 | 2017 | 829 | 0.080 |
Why?
|
| North America | 1 | 2011 | 255 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 663 | 0.080 |
Why?
|
| Hypothermia | 1 | 2011 | 62 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 293 | 0.080 |
Why?
|
| Jugular Veins | 2 | 2022 | 71 | 0.080 |
Why?
|
| Central Nervous System Venous Angioma | 1 | 2010 | 2 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2014 | 451 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 216 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2012 | 190 | 0.080 |
Why?
|
| Cerebellar Nuclei | 1 | 2010 | 11 | 0.080 |
Why?
|
| Diaphragmatic Eventration | 1 | 2009 | 7 | 0.080 |
Why?
|
| Child Development | 2 | 2009 | 266 | 0.080 |
Why?
|
| Contraindications | 1 | 2009 | 75 | 0.080 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2009 | 19 | 0.080 |
Why?
|
| Societies, Medical | 2 | 2025 | 798 | 0.080 |
Why?
|
| Headache | 2 | 2016 | 107 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2010 | 89 | 0.070 |
Why?
|
| Spinal Cord Compression | 1 | 2009 | 30 | 0.070 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 255 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2012 | 348 | 0.070 |
Why?
|
| Occipital Lobe | 1 | 2009 | 31 | 0.070 |
Why?
|
| Surveys and Questionnaires | 4 | 2026 | 4066 | 0.070 |
Why?
|
| Vasculitis | 1 | 2009 | 47 | 0.070 |
Why?
|
| Parietal Lobe | 1 | 2009 | 46 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 1 | 2009 | 99 | 0.070 |
Why?
|
| Cystinosis | 1 | 2009 | 16 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2012 | 363 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2009 | 177 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 589 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 960 | 0.070 |
Why?
|
| Intelligence | 1 | 2009 | 103 | 0.070 |
Why?
|
| Radiography, Panoramic | 1 | 2008 | 6 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2009 | 174 | 0.070 |
Why?
|
| Choroid Plexus | 1 | 2007 | 25 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 6797 | 0.070 |
Why?
|
| United States | 5 | 2026 | 12072 | 0.070 |
Why?
|
| Abortion, Induced | 1 | 2008 | 89 | 0.070 |
Why?
|
| Premature Birth | 1 | 2012 | 428 | 0.070 |
Why?
|
| Palate, Soft | 1 | 2007 | 21 | 0.070 |
Why?
|
| Body Water | 2 | 2004 | 87 | 0.070 |
Why?
|
| Nose Diseases | 1 | 2007 | 7 | 0.060 |
Why?
|
| Trephining | 1 | 2007 | 2 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2006 | 928 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2026 | 3829 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2007 | 49 | 0.060 |
Why?
|
| Rupture, Spontaneous | 1 | 2007 | 50 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 334 | 0.060 |
Why?
|
| Neoplasm, Residual | 1 | 2007 | 136 | 0.060 |
Why?
|
| Ileocecal Valve | 1 | 2006 | 1 | 0.060 |
Why?
|
| Recurrence | 2 | 2001 | 1489 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2009 | 449 | 0.060 |
Why?
|
| Creatine | 1 | 2006 | 37 | 0.060 |
Why?
|
| Facial Nerve Diseases | 1 | 2006 | 6 | 0.060 |
Why?
|
| Choline | 1 | 2006 | 47 | 0.060 |
Why?
|
| Subdural Effusion | 1 | 2006 | 8 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2006 | 72 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 567 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 1280 | 0.060 |
Why?
|
| Biopsy | 1 | 2009 | 1239 | 0.060 |
Why?
|
| Fluoroscopy | 1 | 2026 | 108 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2006 | 149 | 0.060 |
Why?
|
| Sheep | 1 | 2026 | 229 | 0.060 |
Why?
|
| ROC Curve | 2 | 2014 | 613 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2007 | 146 | 0.060 |
Why?
|
| Frontal Sinus | 1 | 2005 | 14 | 0.060 |
Why?
|
| Oximetry | 2 | 2019 | 176 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2007 | 317 | 0.060 |
Why?
|
| Workload | 1 | 2026 | 151 | 0.060 |
Why?
|
| Postoperative Care | 2 | 2005 | 294 | 0.060 |
Why?
|
| Neurocognitive Disorders | 1 | 2005 | 74 | 0.050 |
Why?
|
| Ceftriaxone | 1 | 2005 | 69 | 0.050 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2005 | 80 | 0.050 |
Why?
|
| Fetal Death | 1 | 2005 | 115 | 0.050 |
Why?
|
| Age of Onset | 2 | 2018 | 592 | 0.050 |
Why?
|
| Incidence | 2 | 2025 | 3360 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 445 | 0.050 |
Why?
|
| Supine Position | 1 | 2004 | 24 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2007 | 209 | 0.050 |
Why?
|
| Prone Position | 1 | 2004 | 30 | 0.050 |
Why?
|
| Radiography, Thoracic | 2 | 2015 | 144 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2009 | 804 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2004 | 152 | 0.050 |
Why?
|
| Hypertension | 1 | 2012 | 1356 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 1216 | 0.050 |
Why?
|
| Remission Induction | 1 | 2004 | 306 | 0.050 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2005 | 176 | 0.050 |
Why?
|
| Hypertrophy | 2 | 2014 | 100 | 0.050 |
Why?
|
| Exophthalmos | 1 | 2003 | 28 | 0.050 |
Why?
|
| Urography | 1 | 2003 | 19 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 46 | 0.050 |
Why?
|
| Rupture | 1 | 2003 | 33 | 0.050 |
Why?
|
| Hepatectomy | 1 | 2004 | 131 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 1287 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2003 | 631 | 0.050 |
Why?
|
| Quality of Life | 2 | 2014 | 2082 | 0.050 |
Why?
|
| Seat Belts | 1 | 2003 | 24 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1490 | 0.050 |
Why?
|
| Ophthalmoplegia | 1 | 2003 | 52 | 0.050 |
Why?
|
| Animals | 3 | 2026 | 33912 | 0.050 |
Why?
|
| COUP Transcription Factor I | 1 | 2023 | 54 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 247 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 54 | 0.050 |
Why?
|
| Arabinonucleosides | 1 | 2022 | 33 | 0.050 |
Why?
|
| Nose | 1 | 2003 | 115 | 0.050 |
Why?
|
| Time Factors | 2 | 2018 | 6196 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 294 | 0.050 |
Why?
|
| Perfusion | 1 | 2003 | 209 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 434 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2004 | 400 | 0.040 |
Why?
|
| Cause of Death | 1 | 2004 | 506 | 0.040 |
Why?
|
| Diffusion | 1 | 2001 | 56 | 0.040 |
Why?
|
| Cleft Palate | 1 | 2005 | 221 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2001 | 22 | 0.040 |
Why?
|
| Fetal Movement | 1 | 2021 | 11 | 0.040 |
Why?
|
| Streptococcus agalactiae | 1 | 2022 | 106 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2005 | 398 | 0.040 |
Why?
|
| Clubfoot | 1 | 2021 | 19 | 0.040 |
Why?
|
| Parotid Gland | 1 | 2001 | 18 | 0.040 |
Why?
|
| Safety | 1 | 2001 | 215 | 0.040 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2001 | 61 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2022 | 245 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2001 | 153 | 0.040 |
Why?
|
| Disposable Equipment | 1 | 2020 | 15 | 0.040 |
Why?
|
| Myoglobin | 1 | 2000 | 10 | 0.040 |
Why?
|
| Cytogenetics | 1 | 2000 | 13 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2021 | 162 | 0.040 |
Why?
|
| Career Choice | 1 | 2022 | 166 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 19 | 0.040 |
Why?
|
| Mucin-1 | 1 | 2000 | 32 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2004 | 514 | 0.040 |
Why?
|
| Muscle Hypotonia | 2 | 2012 | 194 | 0.040 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2000 | 34 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2020 | 88 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2000 | 97 | 0.040 |
Why?
|
| Vimentin | 1 | 2000 | 59 | 0.040 |
Why?
|
| Embolism | 1 | 2000 | 38 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2000 | 91 | 0.040 |
Why?
|
| Mandible | 1 | 2001 | 96 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2000 | 116 | 0.040 |
Why?
|
| Research | 1 | 2001 | 264 | 0.040 |
Why?
|
| X Chromosome | 1 | 2001 | 327 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 1 | 2022 | 389 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2014 | 3711 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 39 | 0.040 |
Why?
|
| Colon, Sigmoid | 1 | 1999 | 11 | 0.040 |
Why?
|
| Dyskinesias | 1 | 1999 | 21 | 0.040 |
Why?
|
| Spin Labels | 1 | 2019 | 24 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2001 | 1246 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 2020 | 191 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 726 | 0.040 |
Why?
|
| Dura Mater | 1 | 1999 | 24 | 0.040 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1999 | 4 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2020 | 199 | 0.040 |
Why?
|
| Necrosis | 1 | 2019 | 192 | 0.040 |
Why?
|
| Motor Skills | 1 | 2019 | 72 | 0.040 |
Why?
|
| Neuralgia | 1 | 1999 | 48 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2019 | 216 | 0.040 |
Why?
|
| Antibodies | 1 | 2000 | 322 | 0.040 |
Why?
|
| Craniospinal Irradiation | 1 | 2019 | 58 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2018 | 10 | 0.040 |
Why?
|
| Survival Rate | 1 | 2004 | 2114 | 0.040 |
Why?
|
| Stereotaxic Techniques | 1 | 1999 | 102 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2022 | 281 | 0.040 |
Why?
|
| Thalamus | 1 | 1999 | 93 | 0.040 |
Why?
|
| Urogenital System | 1 | 2018 | 33 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 344 | 0.030 |
Why?
|
| Risk Factors | 2 | 2014 | 11074 | 0.030 |
Why?
|
| Family | 2 | 2014 | 589 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1129 | 0.030 |
Why?
|
| Vascular Neoplasms | 1 | 2018 | 31 | 0.030 |
Why?
|
| Logistic Models | 2 | 2014 | 1797 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 321 | 0.030 |
Why?
|
| Dextromethorphan | 1 | 1997 | 10 | 0.030 |
Why?
|
| Lung | 1 | 2005 | 1535 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 2017 | 15 | 0.030 |
Why?
|
| Spleen | 1 | 2018 | 258 | 0.030 |
Why?
|
| Hypoxia | 1 | 2019 | 247 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 1595 | 0.030 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 1996 | 3 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2022 | 991 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1997 | 124 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 406 | 0.030 |
Why?
|
| Costa Rica | 1 | 1996 | 15 | 0.030 |
Why?
|
| Reticulocytes | 1 | 1996 | 31 | 0.030 |
Why?
|
| Neck Pain | 1 | 2016 | 19 | 0.030 |
Why?
|
| Life Support Systems | 1 | 2016 | 5 | 0.030 |
Why?
|
| Codon | 1 | 1996 | 93 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 1996 | 46 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 216 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1996 | 120 | 0.030 |
Why?
|
| Conservative Treatment | 1 | 2016 | 46 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1997 | 157 | 0.030 |
Why?
|
| Learning | 1 | 2019 | 356 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1996 | 422 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2015 | 89 | 0.030 |
Why?
|
| Colon | 1 | 2018 | 373 | 0.030 |
Why?
|
| Streptococcus anginosus | 1 | 2015 | 10 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2015 | 110 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2015 | 143 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1997 | 361 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 1994 | 12 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 129 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2015 | 180 | 0.030 |
Why?
|
| Steroids | 1 | 2015 | 170 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 786 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 109 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 1826 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2014 | 116 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 242 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 77 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 90 | 0.030 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2013 | 28 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2015 | 190 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 712 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2017 | 426 | 0.030 |
Why?
|
| Amino Acids | 1 | 1996 | 566 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 771 | 0.020 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 209 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2016 | 322 | 0.020 |
Why?
|
| Angelman Syndrome | 1 | 2013 | 68 | 0.020 |
Why?
|
| HIV Infections | 1 | 2005 | 2049 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2014 | 331 | 0.020 |
Why?
|
| Myopia | 1 | 2014 | 121 | 0.020 |
Why?
|
| Epidural Space | 1 | 2012 | 13 | 0.020 |
Why?
|
| Arterial Pressure | 1 | 2013 | 131 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 558 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 2395 | 0.020 |
Why?
|
| Base Sequence | 1 | 1996 | 2730 | 0.020 |
Why?
|
| Fetal Weight | 1 | 2012 | 64 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2012 | 58 | 0.020 |
Why?
|
| Karyotyping | 1 | 2012 | 308 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 286 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 775 | 0.020 |
Why?
|
| Polydactyly | 1 | 2012 | 18 | 0.020 |
Why?
|
| Angiography | 1 | 2012 | 179 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 3464 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2011 | 31 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3686 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 169 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 327 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 79 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 252 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 1796 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1378 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 1692 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1996 | 2550 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2017 | 844 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2013 | 623 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1996 | 1559 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2009 | 18 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1345 | 0.020 |
Why?
|
| Psychology | 1 | 2009 | 62 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 1211 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1173 | 0.020 |
Why?
|
| Nasal Bone | 1 | 2007 | 7 | 0.020 |
Why?
|
| Hypertension, Renal | 1 | 2007 | 30 | 0.020 |
Why?
|
| Respiratory Tract Fistula | 1 | 2007 | 15 | 0.020 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cutaneous Fistula | 1 | 2007 | 21 | 0.020 |
Why?
|
| Cartilage | 1 | 2007 | 52 | 0.020 |
Why?
|
| Osteotomy | 1 | 2007 | 45 | 0.020 |
Why?
|
| Siblings | 1 | 2007 | 201 | 0.010 |
Why?
|
| Cicatrix | 1 | 2007 | 123 | 0.010 |
Why?
|
| Echocardiography | 1 | 2011 | 1125 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 28 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 981 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2007 | 457 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2001 | 76 | 0.010 |
Why?
|
| Protein S Deficiency | 1 | 1999 | 2 | 0.010 |
Why?
|
| Protein C Deficiency | 1 | 1999 | 10 | 0.010 |
Why?
|
| Mastoid | 1 | 1999 | 25 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 142 | 0.010 |
Why?
|
| Heart Failure | 1 | 2012 | 2332 | 0.010 |
Why?
|
| Heparin | 1 | 1999 | 208 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1999 | 267 | 0.010 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 1996 | 2 | 0.010 |
Why?
|
| Spondylitis | 1 | 1996 | 7 | 0.010 |
Why?
|
| Immunologic Tests | 1 | 1996 | 18 | 0.010 |
Why?
|
| Spondylolysis | 1 | 1996 | 3 | 0.010 |
Why?
|
| Intervertebral Disc Displacement | 1 | 1996 | 20 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1996 | 210 | 0.010 |
Why?
|
| Evoked Potentials, Visual | 1 | 1994 | 29 | 0.010 |
Why?
|
| Hemianopsia | 1 | 1994 | 25 | 0.010 |
Why?
|
| Visual Fields | 1 | 1994 | 133 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1994 | 191 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1997 | 863 | 0.010 |
Why?
|
| Visual Acuity | 1 | 1994 | 523 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 2596 | 0.000 |
Why?
|